CVM
CVM
AMEX · Biotechnology

Cel-Sci Corp

$3.48
+0.27 (+8.41%)
As of Apr 1, 3:41 PM ET ·
Financial Highlights (FY 2025)
Revenue
18.47M
Net Income
823.9K
Gross Margin
62.1%
Profit Margin
4.5%
Rev Growth
+3.4%
D/E Ratio
0.78
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 62.1% 62.1% 62.1%
Operating Margin 4.3% 5.2% 4.8%
Profit Margin 4.5% 3.6% 3.5%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 18.47M 17.78M 17.86M
Gross Profit 11.48M 11.05M 11.10M
Operating Income 802.1K 926.3K 849.7K
Net Income 823.9K 633.2K 616.7K
Gross Margin 62.1% 62.1% 62.1%
Operating Margin 4.3% 5.2% 4.8%
Profit Margin 4.5% 3.6% 3.5%
Rev Growth +3.4% -9.1% -0.5%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 12.88M 11.76M 14.30M
Total Equity 16.61M 17.78M 17.70M
D/E Ratio 0.78 0.66 0.81
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 1.32M 1.18M 1.27M
Free Cash Flow 745.4K 469.0K 453.6K